Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urethral Neoplasms × tocilizumab × Clear all

Sponsor

Conditions

Arthritis, Rheumatoid 4 Lymphoma, B-Cell 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Spondylitis, Ankylosing 1 Solid Tumors 1 Sarcoma, Kaposi 1 Respiratory Tract Infections 1 Respiratory Distress Syndrome 1 Pneumonia 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Nasopharyngeal Neoplasms 1 Multi-centric Castleman's Disease 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Kidney Neoplasms 1 Esophageal Neoplasms 1 Castleman Disease 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 COVID-19 1 Biliary Tract Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

Gemcitabine 7 Cisplatin 5 Ramucirumab 3 Platinum 3 Paclitaxel 3 Docetaxel 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 Carboplatin 2 rucaparib 1 pegfilgrastim 1 pazopanib 1 eribulin 1 enzalutamide 1 enfortumab vedotin 1 dehydroftorafur 1 avelumab 1 atezolizumab 1 aflibercept 1 Taxes 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Specimen Handling 1 Sorafenib 1 Radiotherapy 1 Radiation 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1 Mitomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡